StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Sun Pharmaceutical Industries Limited
NSE:SUNPHARMA.NS
Sector
Location
Market Cap
USD 47.22 B
Share Price
USD 19.64
Avg Daily Volume
2,720,780
Change (1 day)
-0.18%
Change (1 year)
5.29%
Change (YTD)
-10.88%
Sun Pharmaceutical Industries Limited Gross Profit Margin for the year ending March 31, 2025: 55.69%
Sun Pharmaceutical Industries Limited Gross Profit Margin is 55.69% for the year ending March 31, 2025, a 15.91% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
-
Sun Pharmaceutical Industries Limited Gross Profit Margin for the year ending March 31, 2024 was 48.05%, a -36.25% change year over year.
-
Sun Pharmaceutical Industries Limited Gross Profit Margin for the year ending March 31, 2023 was 75.36%, a 8.39% change year over year.
-
Sun Pharmaceutical Industries Limited Gross Profit Margin for the year ending March 31, 2022 was 69.53%, a -0.91% change year over year.
-
Sun Pharmaceutical Industries Limited Gross Profit Margin for the year ending March 31, 2021 was 70.17%, a 3.79% change year over year.
Competitors
Eli Lilly and Company
USD 780.10
LLY
+0.82
0.10%
Johnson & Johnson
USD 156.01
JNJ
+0.45
0.29%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
McKesson Corporation
USD 719.30
MCK
+13.85
1.96%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
Elevance Health Inc.
USD 347.84
ELV
-2.41
-0.69%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
Cencora, Inc.
USD 296.23
COR
+5.06
1.74%
Lonza Group AG
USD 698.01
LONN.SW
-5.41
-0.77%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.47
600276.SS
+0.15
2.03%
Takeda Pharmaceutical Company Limited
USD 30.58
4502.T
+0.07
0.24%
Key Data
| Date | Gross Profit Margin | EBIT Margin | EBITDA Margin | Net Income Margin |
|---|
Competitors
Eli Lilly and Company
USD 780.10
LLY
+0.82
0.10%
Johnson & Johnson
USD 156.01
JNJ
+0.45
0.29%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
McKesson Corporation
USD 719.30
MCK
+13.85
1.96%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
Elevance Health Inc.
USD 347.84
ELV
-2.41
-0.69%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
Cencora, Inc.
USD 296.23
COR
+5.06
1.74%
Lonza Group AG
USD 698.01
LONN.SW
-5.41
-0.77%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.47
600276.SS
+0.15
2.03%
Takeda Pharmaceutical Company Limited
USD 30.58
4502.T
+0.07
0.24%